RSS
"Talk to me about reimbursement. Tell me who is going to pay for this." That is what Ron Dollens, retired president and CEO of Guidant Corporation, says is the focus of the med tech industry today. In this discussion, Dollens talks about the emerging trends in the medical technology market. He asserts that the strategic role of policy is encourage investment and innovation.
|
Listen to the Presentation | |
You need Adobe Flash to play this media. Get the flash player here
| |
|
Pointers
Download Audio Presentation (455.7 KB) Download PowerPoint Presentation (1.3 MB) |
|
Keynote Speaker
Ronald W.
Dollens
Retired President and Chief
Executive Officer, Guidant Corporation
Ron Dollens led Guidant Corporation, a Fortune 500 company to its
acquisition in 2006 by Boston Scientific and Abbott in a $27 billion
transaction. His strong policy involvement has led Dollens to be a
renowned leader in the advanced medical device industry. As President
and CEO of Guidant since the company formed in 1994 from a split off
Eli Lilly and Company, Dollens continues to engage in the medical
device community and policy involvement.
